1. Home
  2. TCBS vs MDAI Comparison

TCBS vs MDAI Comparison

Compare TCBS & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Texas Community Bancshares Inc.

TCBS

Texas Community Bancshares Inc.

HOLD

Current Price

$16.65

Market Cap

45.0M

Sector

Finance

ML Signal

HOLD

MDAI

Spectral AI Inc.

HOLD

Current Price

$1.34

Market Cap

43.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCBS
MDAI
Founded
1934
2013
Country
United States
United States
Employees
N/A
78
Industry
Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.0M
43.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TCBS
MDAI
Price
$16.65
$1.34
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$3.25
AVG Volume (30 Days)
1.5K
188.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.21%
N/A
EPS Growth
N/A
N/A
EPS
0.69
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$24.13
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.01
$1.04
52 Week High
$20.00
$3.21

Technical Indicators

Market Signals
Indicator
TCBS
MDAI
Relative Strength Index (RSI) 47.89 36.95
Support Level $15.69 $1.32
Resistance Level $16.69 $1.48
Average True Range (ATR) 0.23 0.07
MACD -0.03 -0.00
Stochastic Oscillator 18.92 17.38

Price Performance

Historical Comparison
TCBS
MDAI

About TCBS Texas Community Bancshares Inc.

Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: